XORTX Financial Statements From 2010 to 2024

XRTX Stock   1.73  0.15  7.98%   
XORTX Therapeutics financial statements provide useful quarterly and yearly information to potential XORTX Therapeutics investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on XORTX Therapeutics financial statements helps investors assess XORTX Therapeutics' valuation, profitability, and current liquidity needs. Key fundamental drivers impacting XORTX Therapeutics' valuation are summarized below:
Market Capitalization
5.6 M
Earnings Share
0.17
There are over one hundred nineteen available fundamental gauges for XORTX Therapeutics, which can be analyzed over time and compared to other ratios. All traders should should confirm XORTX Therapeutics' prevalent fundamental trends against the trends from 2010 to 2024 to make sure the company is sustainable. Market Cap is likely to drop to about 5.5 M in 2024. Enterprise Value is likely to drop to about 2.2 M in 2024
Check XORTX Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among XORTX Therapeutics' main balance sheet or income statement drivers, such as Interest Expense of 0.0, Net Interest Income of 266.2 K or Selling General Administrative of 1.8 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 0.89. XORTX financial statements analysis is a perfect complement when working with XORTX Therapeutics Valuation or Volatility modules.
  
This module can also supplement various XORTX Therapeutics Technical models . Check out the analysis of XORTX Therapeutics Correlation against competitors.
For more information on how to buy XORTX Stock please use our How to Invest in XORTX Therapeutics guide.

XORTX Therapeutics Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Other Current Liabilities5.6 M5.3 M1.7 M
Slightly volatile
Total Current Liabilities280.2 K294.9 KM
Slightly volatile
Accounts Payable186 K195.8 K486.4 K
Pretty Stable
Other Assets1.2 M1.8 M830.4 K
Slightly volatile
Net Receivables36.9 K60.7 K18.9 K
Slightly volatile
Other Stockholder Equity9.7 M9.2 M2.5 M
Slightly volatile
Deferred Long Term Liabilities133.8 K150.5 K163.9 K
Slightly volatile
Total Current Assets6.7 M4.1 M3.3 M
Slightly volatile
Common Stock24.9 M23.7 MM
Slightly volatile
Property Plant Equipment151.6 K144.4 K45.5 K
Slightly volatile
Total Assets8.2 M5.5 M4.2 M
Slightly volatile
Cash6.1 M3.4 M2.8 M
Slightly volatile
Non Current Assets TotalM1.4 M588.6 K
Slightly volatile
Long Term Debt34.6 K38.9 K42.4 K
Slightly volatile
Common Stock Shares Outstanding1.9 MM5.3 M
Pretty Stable
Other Current AssetsM821.9 K789 K
Slightly volatile
Total Liabilities784.6 K825.9 K1.5 M
Slightly volatile
Capital Stock13.2 M17.1 M8.8 M
Slightly volatile
Intangible Assets189.7 K175.3 K259.4 K
Slightly volatile
Short and Long Term Debt40.7 K45.7 K49.8 K
Slightly volatile
Other Liabilities5.4 MM4.8 M
Slightly volatile

XORTX Therapeutics Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Selling General Administrative1.8 M2.2 M1.2 M
Slightly volatile
Research Development1.9 M2.4 MM
Slightly volatile
Total Operating Expenses4.1 MM2.4 M
Slightly volatile
Reconciled Depreciation146.7 K139.7 K38.3 K
Slightly volatile
Interest Income196.1 K255.2 K117.9 K
Slightly volatile

XORTX Therapeutics Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation146.7 K139.7 K38.2 K
Slightly volatile
Capital Expenditures30.1 K46.4 K15.3 K
Slightly volatile
End Period Cash Flow5.2 M3.4 M2.6 M
Slightly volatile
Begin Period Cash Flow11 M10.4 M2.4 M
Slightly volatile
Other Non Cash Items3.2 K3.3 K1.6 M
Slightly volatile
Stock Based Compensation114.9 K121 K117.2 K
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Average Payables348.9 K670.3 K418.7 K
Slightly volatile
Capex To Depreciation0.430.44791.2371
Slightly volatile
Payables Turnover1.010.96290.1838
Slightly volatile
Cash Per Share2.142.2941.7543
Slightly volatile
Days Payables Outstanding3603795.5 K
Slightly volatile
Intangibles To Total Assets0.02310.02430.5151
Slightly volatile
Current Ratio13.3312.69872.7841
Slightly volatile
Graham Number8.4910.01368.611
Slightly volatile
Capex Per Share0.030.03160.1679
Slightly volatile
Average Receivables64.7 K72.8 K79.3 K
Slightly volatile
Interest Debt Per Share0.00440.00460.4007
Slightly volatile
Debt To Assets0.0510.05370.2572
Slightly volatile
Days Of Payables Outstanding3603795.5 K
Slightly volatile
Ebt Per Ebit0.430.4481.0255
Pretty Stable
Quick Ratio13.3312.69872.7945
Slightly volatile
Cash Ratio9.318.86511.9531
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.120.74611.1122
Slightly volatile
Debt Ratio0.0510.05370.2572
Slightly volatile

XORTX Therapeutics Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap5.5 M5.7 M21.2 M
Slightly volatile
Enterprise Value2.2 M2.3 M19.4 M
Slightly volatile

XORTX Fundamental Market Drivers

Forward Price Earnings0.9658

About XORTX Therapeutics Financial Statements

XORTX Therapeutics investors use historical fundamental indicators, such as XORTX Therapeutics' revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in XORTX Therapeutics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for XORTX Stock Analysis

When running XORTX Therapeutics' price analysis, check to measure XORTX Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy XORTX Therapeutics is operating at the current time. Most of XORTX Therapeutics' value examination focuses on studying past and present price action to predict the probability of XORTX Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move XORTX Therapeutics' price. Additionally, you may evaluate how the addition of XORTX Therapeutics to your portfolios can decrease your overall portfolio volatility.